- Exchange: Helsinki
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Biotie Therapies OYJ
+ Add to WatchlistBTH1V:FH
0.3900 EUR 0.0100 2.50%As of 11:30:00 ET on 05/17/2013.
Snapshot for Biotie Therapies OYJ (BTH1V)
| Open: | 0.4000 | Day's Range: | 0.3900 - 0.4000 | Volume: | 95,842 |
|---|---|---|---|---|---|
| Previous Close: | 0.4000 | 52wk Range: | 0.3200 - 0.5000 | 1-Yr Rtn: | 0.00% |
Key Statistics for BTH1V
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. HEXP | - |
| Earnings Per Share (ttm) | -0.0239 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 176.56 |
| Shares Outstanding (M) | 452.71 |
| 30 Day Average Volume | 398,691 |
| Price/Book (mrq) | 1.9888 |
| Price/Sale (ttm) | 8.4881 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (EUR) | - |
| Last Dividend | 03/30/2006 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BTH1V
Company Profile & Key Executives for BTH1V
Biotie Therapies Oyj is a biopharmaceutical company. The Company develops drugs that treat dependence disorders, inflammatory diseases, and thrombosis.
| Timo VeromaaPresident/CEO | David CookChief Financial Officer |
| Stephen I BandakChief Medical Officer | Ian J MasseyCOO & Pres:US Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BTH1V News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page